Insider Transactions
| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Apr 14, 2014 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 15,500 | $11.00 | 42,066 | |
| Jul 12, 2019 | SVP/GM, Global Vascular | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 15,600 | -- | 31,041 | |
| Feb 07, 2005 | VP - Regulatory Affairs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 15,682 | $4.35 | 22,946 | |
| Feb 07, 2005 | VP - Regulatory Affairs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 15,682 | -- | -- | |
| Jul 20, 2022 | EVP and CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,922 | -- | 15,922 | |
| Mar 02, 2005 | VP - Regulatory Affairs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 16,409 | $4.35 | 20,264 | |
| Mar 02, 2005 | VP - Regulatory Affairs | Form 4 | Open market or private sale of non-derivative or derivative security | 16,409 | $22.10 | 3,855 | |
| Mar 02, 2005 | VP - Regulatory Affairs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 16,409 | -- | -- | |
| Dec 15, 2004 | Director, Ten Percent Owner | Form 4 | Bona fide gift | 16,700 | -- | 1,706,415 | |
| Aug 06, 2013 | VP - Global Finance | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 16,740 | -- | 16,740 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.